Tiwari Ramanand, Pandya Darshana H, Baghel Madhav Singh
Assistant Professor, Department of Roga Nidan and Vikrit Vijnana, Dhanwantari Ayurvedic Medical College, Mathura, Uttar Pradesh, India.
Assistant Professor, Department of Roga Nidan and Vikriti Vijnana, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India.
Ayu. 2013 Oct;34(4):368-72. doi: 10.4103/0974-8520.127717.
Irritable bowel syndrome (IBS) is one of the most common conditions encountered in clinical practice but one of the least well understood. Symptoms of this disorder are chronic, sometimes severe and often respond poorly to treatment, resulting in reduced quality of life. There is no specific test for IBS, although diagnostic tests may be performed to rule out other problems. In present clinical trial 51 patients of IBS were registered out of which 46 patients completed the treatment. Bilvadileha was administered for the duration of 12 weeks. The therapy showed statistically significant improvement in all the clinical features of IBS as well as in the IBS severity score.
肠易激综合征（IBS）是临床实践中最常见的病症之一，但也是了解最少的病症之一。这种疾病的症状是慢性的，有时很严重，而且对治疗的反应往往很差，导致生活质量下降。虽然可能会进行诊断测试以排除其他问题，但目前尚无针对IBS的特异性测试。在当前的临床试验中，登记了51例IBS患者，其中46例完成了治疗。给予Bilvadileha治疗12周。该疗法在IBS的所有临床特征以及IBS严重程度评分方面均显示出统计学上的显著改善。
